Lv7
5000 积分 2021-06-27 加入
妇科恶性肿瘤抗HER-2治疗的研究进展
11天前
已完结
Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
25天前
已完结
Where Is the Future of Adjuvant Therapy for Hepatocellular Carcinoma?
1个月前
已关闭
Novel index based on inflammatory markers correlates with treatment efficacy of nivolumab for recurrent/metastatic head and neck cancer
1个月前
已完结
De-Escalation Strategies With Immune Checkpoint Blockers in Non–Small Cell Lung Cancer: Do We Already Have Enough Evidence?
2个月前
已完结
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
2个月前
已完结
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor–Positive, Node-Positive Breast Cancer
3个月前
已关闭
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial
3个月前
已完结
Nab -Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer
3个月前
已完结
Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor–Positive, Node-Positive Breast Cancer
3个月前
已关闭
Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial
2年前
已采纳
滇牡丹花瓣着色过程中类胡萝卜素成分变化和相关基因表达分析
3年前
已采纳
皖公网安备34019202002308
